GABA B receptors are G-protein-coupled receptors that mediate slow synaptic inhibition in the brain and spinal cord. These receptors are heterodimers assembled from GABA B1 and GABA B2 subunits, neither of which is capable of producing functional GABA B receptors on homomeric expression. GABA B1, although able to bind GABA, is retained within the endoplasmic reticulum (ER) when expressed alone. In contrast, GABA B2 is able to access the cell surface when expressed alone but does not couple efficiently to the appropriate effector systems or produce any detectable GABA-binding sites. In the present study, we have constructed chimeric and truncated GABA B1 and GABA B2 subunits to explore further GABA B receptor signaling and assembly. Removal of the entire C-terminal intracellular domain of GABA B1 results in plasma membrane expression without the production of a functional GABA B receptor. However, coexpression of this truncated GABA B1 subunit with either GABA B2 or a truncated GABA B2 subunit in which the C terminal has also been removed is capable of functional signaling via G-proteins. In contrast, transferring the entire C-terminal tail of GABA B1 to GABA B2 leads to the ER retention of the GABA B2 subunit when expressed alone. These results indicate that the C terminal of GABA B1 mediates the ER retention of this protein and that neither of the C-terminal tails of GABA B1 or GABA B2 is an absolute requirement for functional coupling of heteromeric receptors. Furthermore although GABA B1 is capable of producing GABA-binding sites, GABA B2 is of central importance in the functional coupling of heteromeric GABA B receptors to G-proteins and the subsequent activation of effector systems.
GABA is the most widely expressed inhibitory neurotransmitter in the mammalian CNS and mediates its actions via both ionotropic (GABA A /C ) and metabotropic (GABA B ) receptors (Bowery, 1993; Mott and Lewis, 1994; Rabow et al., 1995) . GABA B receptors are members of the group 3 (C) family of G-proteincoupled receptors (GPCRs) (for review, see Couve et al., 2000) , and the modulation of GABA B receptors is thought to be involved in a number of physiological and disease processes, including nociception, cognitive impairment, epilepsy, and spasticity, and also in the etiology of drug addiction . GABA B receptors are unique among the group 3 GPCRs in that they are believed to be heterodimers of GABA B1 and GABA B2 subunits, each of which is unable to form a functional GABA B receptor in its own right (for review, see Marshall et al., 1999) . The heterodimerization of GABA B1b and GABA B2 has been shown to be mediated, at least in part, by interactions between two homologous ␣-helical coiled-coil domains present in the intracellular C terminals of both GABA B1b and GABA B2 (Kammerer et al., 1999; Kuner et al., 1999) . Although the initial papers describing the cloning and expression of GABA B1 reported some functional activity for GABA B1 when expressed alone in mammalian cells (Kaupmann et al., 1997 (Kaupmann et al., , 1998a , a number of subsequent studies have reported that, when expressed alone, GABA B1 is not able to inhibit adenylate cyclase activity effectively (White et al., 1998; Kuner et al., 1999; Ng et al., 1999) , nor can it efficiently couple to K ϩ channels in either Xenopus oocytes (Jones et al., 1998; Kaupmann et al., 1998b; Ng et al., 1999) or human embryonic kidney (HEK)-293 cells (Jones et al., 1998; Kuner et al., 1999) . Furthermore, GABA B1 is unable to inhibit calcium channel activity when injected alone into sympathetic neurons (Couve et al., 1998; Filippov et al., 2000) . These findings are at least partly explained by the fact that, when expressed alone in heterologous systems, GABA B1 is not expressed on the cell surface but is retained within intracellular membranes (Couve et al., 1998) , and although it is able to bind GABA B ligands, its pharmacological profile with respect to agonist binding is different from that of endogenous receptors (Kaupmann et al., 1997) . However, coexpression of GABA B1 with GABA B2 results in the correct trafficking of both subunits to the cell surface as heterodimers and the formation of functional receptors with pharmacology similar to that of GABA B receptors in vivo (Jones et al., 1998; Kaupmann et al., 1998b; White et al., 1998; Kuner et al., 1999; Ng et al., 1999) . Thus the dimerization of GABA B2 with GABA B1 results in an increase in the affinity of the receptor for GABA B agonists, despite the fact that agonists are thought to bind specifically to GABA B1 , showing that there is some form of cooperativity in ligand binding between GABA B1 and GABA B2 (for review, see Bowery and Enna, 2000) .
In this study we have generated a number of C-terminal truncations of GABA B1 and chimeric subunits between GABA B1 and GABA B2 and used these molecules to investigate the roles of the two subunits in the intracellular trafficking and downstream signaling of GABA B receptors.
MATERIALS AND METHODS
Construction of truncated and chimeric GA BA B receptor subunits. A f ull-length human GABA B1b cDNA was tagged by site-directed mutagenesis (Transformer SDM kit; C lontech, C ambridge, UK) with the c-myc epitope (EQK LISEEDL) recognized by the 9E10 mouse monoclonal antibody (Roche Diagnostics). The tag was introduced after amino acid 35 of the nascent protein. GABA B2 was hemagglutinin (HA)-tagged (AAAYPYDV PDYA; recognized by 3F10 rat monoclonal antibody; Roche Diagnostics) after amino acid 42 of the nascent protein. Both f ull-length cDNAs were cloned into pcDNA3.1 (Invitrogen, San Diego, CA). GABA B1b and GABA B2 deletion mutants and chimeras were generated by PCR from these f ull-length, tagged subunit cDNAs. All the PCR primers used had HindIII restriction enzyme sites engineered into them to facilitate cloning and are described in Table 1 . GABA B1b ⌬806 and GABA B1b ⌬771 were amplified in single PCR reactions and cloned into pcDNA3.1/V5-His. GABA B1b ⌬747 and GABA B2 ⌬748 were generated by PCR and cloned into pCMV-5 (Stratagene, La Jolla, CA). GABA B2/1bC was generated by ligation of GABA B2 ⌬748 and GABA B1b (750 -844) and cloned into pcDNA3.1 (Invitrogen). GABA B1b/2C was generated by ligation of GABA B1 ⌬747 and GABA B2 (751-941) and cloned into pcDNA3.1. The truncated and chimeric receptor subunits are all shown schematically in Figure 1 . All experiments were performed using epitope-tagged wild-type, deletion, and chimeric receptor subunits unless otherwise stated.
Culture and transfection of HEK-293 cells. All cell culture reagents were obtained from Life Technologies, Paisley, UK . H EK-293 cells were maintained in DM EM supplemented with 10% fetal calf serum and 1% nonessential amino acids. E xponentially growing cells were transfected using Lipofectamine Plus (Life Technologies) according to the manufacturer's instructions and then incubated for 24 hr to allow for protein expression before analysis.
Antibodies and immunofluorescence. A rabbit antiserum specific for GABA B1b was raised against the peptide CHSPHL PRPHPRV PPHPS (amino acids 31-47) and affinity purified as described previously (C alver et al., 2000) . The rabbit antiserum specific for GABA B2 was raised against a GST f usion protein, which contained the entire intracellular C terminal of the rat GABA B2 protein (amino acids 745-941), and has been described previously (C alver et al., 2000) .
For immunocytochemistry, cells on glass coverslips were fixed with 4% paraformaldehyde for 5 min and then either permeabilized with 0.1% Triton X-100 for 10 min or washed with PBS. C ells were incubated in primary antibody (anti c-myc or anti-HA; 1:5000 in PBS; 60 min), washed in PBS, and then incubated in goat anti-mouse IgG-FI TC (for anti c-myc) or goat anti-rat IgG-FI TC (for anti-HA; both obtained from Sigma, Poole, UK , and used at 1:100 in PBS; 45 min). C ells were then washed in PBS, mounted in C itifluor (C itifluor, L ondon, UK), and viewed using a Leica laser-scanning confocal microscope.
Immunoprecipitation and Western blotting. Crude membranes from rat whole brain were prepared as described previously (Benke et al., 1999) . Transiently transfected H EK-293 cells were lysed with ice-cold 1% (v/ v) Triton X-100 including protease inhibitors (protease inhibitor cocktail tablets; Roche Diagnostics). After centrif ugation the lysate supernatants were precleared with normal rabbit serum and then incubated overnight with anti-GABA B1b antibody (5 g). Antigen -antibody complexes were immunoprecipitated with Protein A-Sepharose, washed extensively in PBS containing Triton X-100, and then resuspended in sample buffer containing 2% (v/ v) 2-mercaptoethanol and boiled for 5 min. Eluted proteins were resolved by discontinuous SDS-PAGE and transferred to a poly vinylidene difluoride membrane using a semidry transfer system (Bio-Rad, Hercules, CA). The membranes were blocked with 5% nonfat milk in PBS and 0.05% T ween 20 and then incubated overnight with anti-GABA B2 antibody at 0.1 g /ml in blocking solution. Immunoreactive bands were detected with a goat anti-rabbit antibody conjugated to horseradish peroxidase followed by chemiluminescence detection (ECL; Amersham).
Radioligand binding. Transfected cells were homogenized in ice-cold 50 mM Tris-HC l and 2.5 mM MgC l 2 buffer, pH 7.4, using a K inematic Ultra-T urrax homogenizer. The homogenates were then centrif uged at 35,000 ϫ g for 15 min at 4°C. Membrane pellets were resuspended in the buffer and homogenized and centrif uged as before. The final membrane pellet was resuspended in buffer and stored at Ϫ80°C until required. Binding assays consisted of 50 l of displacing compound or buffer, 400 l of membrane suspension (corresponding to ϳ30 g of protein / well), and 50 l of [ 3 H]CGP-54626 (specific activity, 40 C i /mmol). In competition binding experiments, 10 concentrations of the competing ligands were tested, at a final [
3 H]CGP-54626 concentration of 2 nM. Nonspecific binding was defined using 1 mM GABA or 10 M CGP-62349. The experiments were terminated by rapid filtration over Whatman GF/ B glass fiber filters, presoaked with 0.3% (v/ v) polyethyleneimine, and washed with 6 ml of ice-cold 50 mM Tris-HC l buffer. Radioactivity was determined by liquid scintillation spectrometry using a Packard 2700 liquid scintillation counter. The concentration of GABA inhibiting specific [
3 H]CGP-54626 binding by 50% (IC 50 ) was determined by iterative curve fitting using a four-parameter logistic fit (Grafit, Erithacus Software). pKi values (Ϫlog of the inhibition constant) were then calculated from the IC 50 values by the method described by Cheng and Prusoff (1973) ; the K D had been determined previously in the present system and was 4.2 Ϯ 0.8 nM (data not shown).
Calcium mobilization assay. Transfected cells were seeded into blackwalled 96-well plates (Corning Costar L td.) at a density of 30,000 cells/ well and incubated at 37°C in 5% C O 2 for 24 hr before use. C ells were loaded with media containing 4 M Fluo-3 (Molecular Probes, Eugene, OR), a C a 2ϩ -sensitive dye, in the presence of 2.5 mM probenecid and incubated for 60 min at 37°C in 5% C O 2 . C ells were then washed four times with 125 l of modified T yrode's buffer (145 mM NaC l, 2.5 mM KC l, 10 mM H EPES, 10 mM glucose, 1.2 mM MgC l 2 , 2.5 mM probenecid, and 0.15 mM CaCl 2 ) and then incubated in 150 l of the same buffer for 20 min at 37°C in 5% C O 2 . Agonist was added, and the resulting intracellular calcium mobilization was recorded using a fluorimetricimaging plate reader (FLI PR; Molecular Devices, Palo Alto, CA). Peak fluorescence was determined for each agonist addition, and the data were iteratively curve-fitted using a four-parameter logistic model (Bowen and Jerman, 1995) . In addition to H EK-293 cells, all of the f unctional data presented here have been repeated and confirmed in another cell line, Chinese hamster ovary (CHO)-K1 cells (data not shown).
RESULTS

Intracellular retention of GABA B1 is mediated by the coiled-coil motif within the C terminal of the protein
Using PCR amplification from a full-length, myc-tagged GABA B1 cDNA, we constructed a number of truncated coding sequences for this subunit and subcloned them into mammalian expression vectors, as described in Materials and Methods and Table 1 . The first of these, GABA B1b ⌬806, was a truncation removing the most distal part of the C terminal, up to the end of the coiled-coil domain shown previously to be involved in the interaction with GABA B2 (Kammerer et al., 1999; Kuner et al., 1999) . The second truncation (GABA B1b ⌬771) was similar but removed an additional 35 amino acids covering the GABA B2 -interacting stretch of the coiled-coil domain. The final truncation of GABA B1b (GABA B1b ⌬747) removed the entire intracellular C terminal except the four amino acids downstream of the putative seventh transmembrane domain (Fig. 1) . As expected, when transfected into HEK-293 cells in isolation, GABA B1b was not detected by immunocytochemistry on the cell surface but could only be visualized after permeabilization of the cells with detergent ( Fig.  2 A,B) (Couve et al., 1998) . Similarly, GABA B1b ⌬806 was not expressed on the cell surface but could be detected after membrane disruption with Triton X-100 (Fig. 2C,D) . In contrast however, GABA B1b ⌬771, which lacks the coiled-coil domain shown previously to interact with GABA B2 , was readily detectable by immunofluorescence on the cell surface of intact transfected cells, as well as after permeabilization (Fig. 2 E,F ) . In addition, the truncated GABA B1b subunit lacking the entire C terminal, GABA B1b ⌬747, was also expressed on the cell surface at levels ( C-H) . All of the full-length and truncated subunits were tagged with a c-myc epitope recognized by the 9E10 antibody. Transfected cells were examined after 24 hr by immunofluorescence using the 9E10 antibody either with (B, D, F, H ) or without (A, C, E, G) permeabilization. GABA B1b and GABA B1b ⌬806 are both retained intracellularly ( A-D), whereas GABA B1b ⌬771 and GABA B1b ⌬747 are both expressed on the cell surface ( E-H). Insets, Diagrams of the truncations are shown, with the coiled-coil region necessary for receptor dimerization indicated in red. All of the transfections were performed and analyzed at least three times, and the results with each construct were consistent. Scale bar, 10 m. similar to those obtained in cotransfection experiments with GABA B2 (Fig. 2G,H ) . Thus the normal intracellular retention of GABA B1b in the absence of GABA B2 is mediated via the putative ␣-helical coiled-coil motif in the same region in which the GABA B1b -GABA B2 interaction occurs.
The C-terminal domain of GABA B1 is sufficient to sequester GABA B2 within the cell We were therefore interested in whether the intracellular C-terminal tail of GABA B1b was able to redirect the normally cell surface-expressed GABA B2 subunit to intracellular membranes. To investigate this, we replaced the entire intracellular tail of GABA B2 (amino acids 751-941) with the equivalent domain of GABA B1b (amino acids 750 -844) to generate the chimeric subunit GABA B2/1bC (Fig. 1) . As a control, we also generated a truncated GABA B2 subunit that lacked the entire intracellular tail (GABA B2 ⌬748; Fig. 1 ). When expressed alone in transient transfections, full-length GABA B2 is transported to and detectable by immunocytochemistry both on the cell surface (Fig. 3A) and intracellularly ( Fig. 3B ), as has been described previously (Martin et al., 1999) . Similarly, our deletion mutant GABA B2 ⌬748 could be detected readily in transfected cells both with and without detergent permeabilization and with the same cellular distribution as its full-length counterpart (Fig. 3C,D) . However, when the chimeric receptor subunit GABA B2/1bC was expressed transiently in HEK-293 cells, although intracellular expression was seen after permeabilization, there was no evidence of transport of the subunit to the plasma membrane (Fig. 3E,F ) . When this chimera was coexpressed transiently with wild-type GABA B2 , however, this intracellular retention was overcome, and the chimeric GABA B2/1bC was transported to the cell surface (Fig. 3G,H) . The full-length GABA B2 used for this cotransfection was not tagged with the HA epitope, so the immunofluorescence seen using the anti-HA antibody 3F10 on unpermeabilized cells was specific to the HA-tagged GABA B2/1bC . C-terminally truncated GABA B1b subunits are able to bind GABA We investigated the effect of C-terminal truncation and subsequent cell surface localization of the GABA B1b ⌬747 subunit on the ability of the subunit to bind GABA. Removal of the intracellular C terminal of GABA B1b had no effect on the ability of GABA to displace the antagonist CGP-54626 in competition binding assays. Furthermore, the potency of GABA at this truncated receptor subunit was not significantly different from its potency at the full-length GABA B1b subunit (Fig. 4) ( p Ͻ 0.001, one-way ANOVA with post hoc t test). As has been reported previously (for review, see Bowery and Enna, 2000) , coexpression of GABA B1b with GABA B2 resulted in a significant increase in the potency of GABA binding compared with GABA binding at GABA B1b alone, and such a shift in potency was also observed when the truncated GABA B1b subunit was coexpressed with GABA B2 (Fig. 4) ( p Ͻ 0.001, one-way ANOVA with post hoc t test).
C-terminally truncated GABA B1b subunits are nonfunctional when expressed alone but couple to Gproteins when coexpressed with GABA B2
To determine whether cell surface expression of the GABA B1b subunit was sufficient to form a functional GABA B receptor, we tested the ability of C-terminally truncated GABA B1b to activate Figure 3 . The C-terminal domain of GABA B1b is sufficient to sequester GABA B2 within the cell. A-H, HEK-293 cells were transfected with constructs encoding either the full-length GABA B2 (A, B), GABA B2 ⌬748 (C, D), GABA B2/1bC (E, F ), or GABA B2/1bC ϩ GABA B2 (G, H ). All of the fulllength and truncated subunits were tagged with an HA epitope recognized by the 3F10 antibody, except for the full-length GABA B2 used in the cotransfection (G, H ) that was not epitope-tagged. Transfected cells were examined after 24 hr by immunofluorescence using the 3F10 antibody either with (B, D, F, H ) or without (A, C, E, G) permeabilization. Both full-length GABA B2 and GABA B2 ⌬748 when transfected alone are expressed on the cell surface ( A-D), whereas GABA B2/1bC is retained within the cell (E, F ). The HAtagged GABA B2/1bC is able to reach the cell surface and be detected by anti-HA, however, when coexpressed with the untagged GABA B2 (G, H ). Insets, Diagrams of the truncations and chimeras are shown; GABA B2 sequences are shown in red, whereas GABA B1b sequences are shown in black. All of the transfections were performed and analyzed at least three times, and the results with each construct were consistent. Scale bar, 10 m.
G-proteins in response to GABA. Although GABA B receptors are known to inhibit adenylate cyclase via their interaction with G i , we cotransfected the chimeric G-protein G qi5 (Conklin et al., 1993) in transient transfections so that stimulation of a GABA B receptor would activate the phospholipase C pathway, resulting in mobilization of intracellular calcium, which could then be measured on a FLIPR. Coexpression of GABA B1b and GABA B2 together with Gqi5 in HEK-293 cells resulted in robust calcium mobilization in response to agonist, whereas coexpression of GABA B1b and Gqi5 gave no response in this functional assay, even at a GABA concentration of 0.1 mM (Fig. 5A ). When we tested the cell surface-expressed C-terminally truncated GABA B1b ⌬747 with Gqi5 in this system, it also exhibited no functional coupling to the G-protein when expressed on its own (Fig. 5A) .
We next tested the effect of coexpression of the GABA B2 subunit with the C-terminally truncated GABA B1b on the coupling of the receptor to the chimeric G-protein Gqi5. Both the f ull-length GABA B1b subunit and the C -terminally truncated GABA B1b ⌬747, when coexpressed with GABA B2 , were capable of activating Gqi5 and activating the downstream phospholipase C pathway (Fig. 5B) . The f unctional response of the truncated GABA B1b with GABA B2 , as measured by the EC 50 in response to GABA, was not significantly different from that of the wild-type GABA B1b subunit expressed with GABA B2 [pEC 50 (GABA B1b ϩ GABA B2 ) ϭ 7.08 Ϯ 0.02; pEC 50 (GABA B1b ⌬747 ϩ GABA B2 ) ϭ 6.93 Ϯ 0.05; n ϭ 4 -6]. In addition to H EK-293 cells, all of the f unctional experiments presented here have also been performed in another cell line, CHO-K1 cells, with qualitatively identical results.
Functional coupling of the GABA B receptor to Gproteins requires neither the C-terminal of GABA B1b nor the C-terminal of GABA B2
Because we had shown that the C-terminal domain of GABA B1b was not necessary for GABA B receptor heterodimers to couple functionally to Gqi5, we investigated the importance of the C-terminal of GABA B2 with respect to the correct functionality of the receptor. We again performed the calcium mobilization assay experiments on the FLIPR, using cells transiently transfected with the C-terminally truncated GABA B1b ⌬747, a C-terminally truncated GABA B2 subunit (GABA B2 ⌬748), and Gqi5. This also resulted in the expression of a receptor complex capable of coupling to Gqi5 (Fig. 5C) . The EC 50 of this response was significantly lower than that for the wild-type receptor ( p Ͻ 0.001, F test), although it is unclear whether this reflects genuine differences in the ability of the mutant receptor subunits to couple to G-proteins in a nontransient system [pEC 50 (GABA B1b ⌬747 ϩ GABA B2 ⌬748) ϭ 6.34 Ϯ 0.01].
The C-terminal interaction between GABA B1 and GABA B2 is not necessary for the formation of heterodimers
It has been well documented that GABA B1b and GABA B2 form heterodimers, both in transfected cells and in native tissues, and that the only reported region of dimerization is between the ␣-helical coiled-coil motifs present in the C terminals of the two subunits (Kammerer et al., 1999; Kuner et al., 1999 ). However we have demonstrated here that this interaction is not necessary for a functional response of GABA B receptor heterodimers. We performed immunoprecipitation experiments to investigate further whether this coiled-coil interaction was indeed necessary for heterodimerization of GABA B1b and GABA B2 subunits. We raised antibodies in rabbits against an N-terminal peptide of GABA B1b (see Materials and Methods) that recognized single bands on Western blots both with cells transfected with GABA B1b and with brain membranes (Fig. 6 A) . We did consistently observe a small difference in size between the human tagged recombinant GABA B1b and the rat brain-derived GABA B1b , but we would suggest that this may reflect differences in expression and posttranslational modification between the recombinant human and endogenous rat receptor subunits. Both these bands could be specifically blocked by preincubation of the antiserum with the immunizing peptide (data not shown). After immunoprecipitation with anti-GABA B1b and immunodetection on Western blots with anti-GABA B2 (Calver et al., 2000) , heterodimers could be readily detected in membrane preparations from cells transfected with both full-length subunits together but not in cells transfected with either GABA B1b ⌬748 or GABA B2 alone (Fig. 6 B) . However, when GABA B2 was transiently coexpressed with GABA B1b lacking a C terminal, a band corresponding to GABA B2 was detected after immunoprecipitation with anti-GABA B1b and immunoblotting with anti-GABA B2 antibodies (Fig. 6 B) . Although this band is less intense than that observed after coexpression of the two full-length subunits, it nevertheless indicates that GABA B1b and GABA B2 are capable of forming heterodimers in the absence of the C-terminal coiled-coil interaction. Other bands were also observed in all lanes above and below those corresponding to GABA B2 , but these were also observed in untransfected cells (Fig. 6 B, lane 1) and thus represent nonspecific bands unrelated to the transfected GABA B cDNAs. Removal of the C terminal of GABA B1b does not affect ligand binding. Cells transiently transfected with either GABA B1b alone, GABA B1b ϩ GABA B2 , GABA B1b ⌬747 alone, or GABA B1b ⌬747 ϩ GABA B2 specifically bound [
3 H]CGP-54626, and this could be completely displaced by GABA (10 mM), with pKi values of 3.60 Ϯ 0.13, 4.14 Ϯ 0.05, 3.70 Ϯ 0.10, and 4.00 Ϯ 0.09, respectively. Data are expressed as means Ϯ SEM (n ϭ 4 -6). All receptor subunits were epitope-tagged as described in Materials and Methods.
DISCUSSION
We have shown in this study that the C -terminal intracellular domain of the GABA B1b receptor subunit is responsible for the retention of the subunit within the cell when expressed in the absence of GABA B2 . When this domain is removed from the GABA B1b subunit, the truncated GABA B1b is trafficked to the cell surface independently of GABA B2 . We have also shown that the C -terminal stretch of 35 amino acids responsible for intracellular retention is the same domain that mediates the interaction etween GABA B1b and GABA B2 and is situated within the putative "coiled-coil" domain between amino acids 771 and 806 of GABA B1b . In addition, the C -terminal domain of GABA B1b is sufficient to cause the normally cell surface-4 or GABA B1b ⌬747 on their own, whereas a robust functional response was seen when GABA B1b was cotransfected with GABA B2 (pEC 50 ϭ 7.08 Ϯ 0.02). B, A similar response was seen when GABA B2 was cotransfected with GABA B1b ⌬747 or when GABA B2 was cotransfected with GABA B1b [pEC 50 (GABA B1b ϩ GABA B2 ) ϭ 7.08 Ϯ 0.02; pEC 50 (GABA B1b ⌬747 ϩ GABA B2 ) ϭ 6.93 Ϯ 0.05]. C, A functional GABA B receptor was also detected in FLIPR when GABA B1b ⌬747 was cotransfected with GABA B2 ⌬748 and Gqi5 (pEC 50 ϭ 6.34 Ϯ 0.01). The data in A-C are taken from a single representative experiment. All receptor subunits were epitope-tagged as described in Materials and Methods. expressed GABA B2 to be retained within the cell, when it is exchanged for the equivalent region of the native GABA B2 (chimera GABA B2/1bC ). There are a number of other examples in which the C terminal of a receptor or ion channel is responsible for its intracellular retention in the absence of accessory molecules (McI lhinney et al., 1998; Z erangue et al., 1999) . For example, the ionotropic NMDA receptor subunit N R1 is retained within cells in the absence of the N R2 subunit (McI lhinney et al., 1998) . This intracellular retention appears to be mediated by the C terminal of the N R1 protein, because splice variants in this region are able to reach the cell surface in the absence of N R2 (Okabe et al., 1999) . In addition, GPCRs for which the C terminal appears to be important for targeting to the plasma membrane include the metabotropic glutamate receptors (Stowell and Craig, 1999; Chan et al., 2000) and the serotonin receptor 5-HT 1B (Jolimay et al., 2000) .
The intracellular retention of the chimeric GABA B2/1bC can be overcome by the coexpression of GABA B2/1bC with the fulllength GABA B2 , presumably as a result of the interaction between the two C terminals. These data suggest that the coiled-coil interaction between GABA B2 and GABA B1b competes with a similar coiled-coil interaction between GABA B1b and another unknown, presumably ER-associated protein, which in the absence of GABA B2 mediates the retention of the GABA B1b subunit within the ER. This would not be surprising because coiledcoil motifs are secondary structures present in a large number of proteins and have been implicated in the formation of several multimeric protein complexes (Lupas, 1996) .
It is known that expression of GABA B1b alone results in the formation of nonfunctional GABA B receptors, at least in part because of the fact that when expressed alone it is not present on the cell surface (Couve et al., 1998) . However, cell surface expression of GABA B1 alone is not sufficient to form a functional GABA B receptor, as demonstrated by a recent study in which coexpression of metabotropic glutamate receptor 4 (mGluR4) in Xenopus oocytes resulted in cell surface expression of GABA B1 , although not as a GABA B1 -mGluR4 heterodimer (Sullivan et al., 2000) . In this system the GABA B1 subunit was unable to couple to members of the Kir3.0 family of potassium channels or to couple negatively to adenylate cyclase. The results we present here support these findings, because the C-terminally truncated cell surface-expressed GABA B1b subunit, when expressed alone, binds GABA but is unable to couple functionally to the chimeric G-protein Gqi5. It is only by coexpressing the truncated GABA B1b with GABA B2 that we were able to reconstitute a functional G-protein-coupled receptor. Interestingly we also detected a functional receptor when we coexpressed the C-terminally truncated GABA B1b with C-terminally truncated GABA B2 . This suggests that neither of the intracellular C terminals of GABA B1b or GABA B2 is necessary for the coupling of the GABA B receptor to its second messenger system, although we cannot exclude the possibility that the functionality of the receptor is altered in a more subtle manner by such deletions. This is consistent with the findings of Gomeza et al. (1996) , who demonstrated that although all of the intracellular domains of mGluR1 play a role in G-protein coupling, none of them apart from intracellular loop two is absolutely required for the activation and downstream signaling of this receptor.
The data presented here also suggest that it may be the GABA B2 subunit that binds to G-proteins and subsequently initiates the downstream signaling cascades. Alternatively, it may be that the intracellular loops of GABA B1b are in fact the important regions for G-protein coupling and that the presence of GABA B2 is required for GABA B1b to assume the correct tertiary structure to mediate this interaction. However, when one compares the sequences of the intracellular loops of GABA B2 with those of GABA B1 and the other seven transmembrane receptors that are known to bind and couple to G-proteins , it is not unreasonable to suggest that the amino acids present in the GABA B2 subunit intracellular loops render it a more attractive candidate for G-protein coupling than do the corresponding residues present in GABA B1 .
As well as trafficking and G-protein coupling, our data have novel implications for the heterodimerization of GABA B receptors, which until now has been thought to be solely mediated by the C-terminal coiled-coil interaction between GABA B1b and GABA B2 . In this study, we have shown that when the intracellular tail of GABA B1b is removed, the resulting truncated subunit is still capable of forming functional heterodimers with GABA B2 , although the efficiency of the heterodimerization is reduced. This demonstrates that other sequences exist within the two GABA B subunits that must be capable of interacting with each other. It is unclear from the data presented here whether this interaction occurs within the extracellular N terminals of the subunits or alternatively within the transmembrane domains, but further truncation and chimera experiments are in progress to identify such interactions. Other GPCRs have been shown to heterodimerize, such as the and ␦ opioid receptors (Jordan and Devi, 1999) and the somatostatin (SST5) and dopamine (D 2 ) receptors (Rocheville et al., 2000) , in the absence of C-terminal coiled-coil domains. Such receptors must therefore use other protein-protein interactions to form dimers. Interestingly, the interaction between SST5 and D 2 was demonstrated recently by the functional rescue of an inactive C-terminally truncated SST5 receptor by a full-length D 2 receptor, demonstrating that a C-terminal interaction between these two receptors is not necessary for the formation of heterodimers (Rocheville et al., 2000) .
In summary, our data support a model in which the GABA B1b subunit, when expressed alone, is retained within the cell by protein-protein interactions between its C-terminal coiled-coil domain and, presumably, components of the ER. In the presence of GABA B2 , the equivalent coiled-coil domain in the C terminal of GABA B2 competes for these interactions, and thus the intracellular retention of GABA B1b is overcome, and the subunit is able to reach the cell surface. In addition, the elements of the GABA B receptor responsible for G-protein coupling are probably not present within the C terminal of either the GABA B1b or the GABA B2 subunit and may indeed lie within the intracellular domains of GABA B2 .
Notes added in proof. Since the submission of this manuscript, two papers have appeared in press that confirm a number of our observations. First, Margeta-Mitrovic et al. (2000) have reported the presence of an intracellular retention motif in the C terminal of GABA B1 , although, in contrast to the data shown in our paper, they also report that the C-terminal coiled-coil interaction between GABA B1 and GABA B2 is necessary to form a functional GABA B receptor. Second, Schwartz et al. (2000) have identified a splice variant of GABA B1, termed GABA B1e, consisting of just the extracellular N terminal of GABA B1. This subunit is capable of forming (nonfunctional) heterodimers with GABA B2, confirming that the coiled-coil interaction is not necessary for the heterodimerization of GABA B receptors. The data presented here both confirm and extend these observations.
